China's drug regulator approved Beijing Wandong Medical Technology's (SHA:600055) X-ray machine for medical angiography, according to a Saturday filing with the Shanghai bourse.
The approval is valid for five years, until May 18, 2031.
Related Articles
Asia
Taiji Industry Gets China Supplementary Nod for Heart Failure Injection
China's drug regulator approved Chongqing Taiji Industry's (SHA:600129) supplementary drug application for its digoxin injection, according to a Saturday filing with the Shanghai bourse.The injection helps treat mild to moderate heart failure in adults and increases cardiac force in children with heart failure, the filing said.
$SHA:600129
Asia
Kalpataru Clinches Cluster Redevelopment Project in Mumbai, India
Real estate developer Kalpataru (NSE:KALPATARU, BOM:544423) has secured a cluster redevelopment project comprising five adjacent residential societies in the Kandivili area of Mumbai, India, according to a Monday filing to the Indian stock exchanges.The project spans 2.8 acres of land with a free sale potential of 0.37 million square feet (msf) carpet area and an estimated gross development value of around 12.5 billion rupees.The company has already delivered six development projects in the Kandivili area.
$BOM:544423$NSE:KALPATARU
Asia
Huluwa Pharma's Zoledronic Acid Concentrate for Injection Gets Registration Certificate
Hainan Huluwa Pharmaceutical's (SHA:605199) zoledronic acid concentrate for injection obtained a drug registration certificate from China's National Medical Products Administration, according to a Shanghai bourse filing on Saturday.The pharmaceutical company's shares jumped 3% at the close of Monday's trade.The drug is used in combination with standard antitumor therapy for the treatment of skeletal complications in patients with bone metastases from solid tumors and multiple myeloma.
$SHA:605199